Narrative Update • Jun 15
Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedJun 25, 2026
DataAggregated Company Financials
Companies9
- 7D2.5%
- 3M13.6%
- 1Y19.6%
- YTD10.6%
In the last week, the Biotech industry is up 2.5%, with Biocon up 2.1%. In the last 12 months, the industry was up 20%. Looking forward, earnings are forecast to grow by 48% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Jun 2026 | ₹743.7b | ₹181.4b | ₹4.5b | 34.3x | 165.3x | 4.1x |
| Sat, 23 May 2026 | ₹747.3b | ₹181.9b | ₹4.6b | 44.1x | 162.9x | 4.1x |
| Mon, 20 Apr 2026 | ₹622.4b | ₹180.6b | ₹6.7b | 64x | 93.3x | 3.4x |
| Wed, 18 Mar 2026 | ₹647.6b | ₹180.6b | ₹6.7b | 52.2x | 97.1x | 3.6x |
| Fri, 13 Feb 2026 | ₹647.6b | ₹177.1b | ₹5.5b | 61.9x | 118x | 3.7x |
| Sun, 11 Jan 2026 | ₹615.3b | ₹177.0b | ₹5.5b | 91.7x | 111.5x | 3.5x |
| Tue, 09 Dec 2025 | ₹551.7b | ₹177.0b | ₹5.5b | 90.8x | 100x | 3.1x |
| Thu, 06 Nov 2025 | ₹555.2b | ₹169.8b | ₹4.6b | 103.3x | 119.5x | 3.3x |
| Sat, 04 Oct 2025 | ₹517.5b | ₹169.4b | ₹4.6b | 60.7x | 111.8x | 3.1x |
| Mon, 01 Sep 2025 | ₹514.3b | ₹169.4b | ₹4.6b | 64x | 111x | 3x |
| Wed, 30 Jul 2025 | ₹579.4b | ₹163.7b | ₹10.6b | 54.9x | 54.5x | 3.5x |
| Fri, 27 Jun 2025 | ₹514.8b | ₹163.8b | ₹10.6b | 51.2x | 48.5x | 3.1x |
| Sun, 25 May 2025 | ₹450.3b | ₹163.8b | ₹10.6b | 55.5x | 42.5x | 2.7x |
| Tue, 22 Apr 2025 | ₹450.5b | ₹158.8b | ₹8.5b | 49.5x | 52.8x | 2.8x |
| Thu, 20 Mar 2025 | ₹453.6b | ₹158.9b | ₹8.4b | 50.9x | 54.3x | 2.9x |
| Sat, 15 Feb 2025 | ₹459.7b | ₹158.7b | ₹8.3b | 52x | 55.5x | 2.9x |
| Mon, 13 Jan 2025 | ₹486.2b | ₹159.6b | ₹14.5b | 59.8x | 33.4x | 3x |
| Wed, 11 Dec 2024 | ₹499.3b | ₹159.6b | ₹14.5b | 42.7x | 34.3x | 3.1x |
| Fri, 08 Nov 2024 | ₹446.6b | ₹159.0b | ₹14.3b | 43.1x | 31.2x | 2.8x |
| Sun, 06 Oct 2024 | ₹462.6b | ₹157.7b | ₹15.7b | 32x | 29.4x | 2.9x |
| Tue, 03 Sep 2024 | ₹477.4b | ₹157.7b | ₹15.7b | 35.4x | 30.4x | 3x |
| Thu, 01 Aug 2024 | ₹477.4b | ₹157.4b | ₹10.4b | 53.4x | 46.1x | 3x |
| Sat, 29 Jun 2024 | ₹454.6b | ₹157.4b | ₹10.4b | 43.9x | 43.7x | 2.9x |
| Mon, 27 May 2024 | ₹412.1b | ₹157.0b | ₹10.2b | 45x | 40.3x | 2.6x |
| Wed, 24 Apr 2024 | ₹364.6b | ₹155.4b | ₹12.0b | 37x | 30.3x | 2.3x |
| Fri, 22 Mar 2024 | ₹324.0b | ₹155.4b | ₹12.0b | 32.9x | 27x | 2.1x |
| Sun, 18 Feb 2024 | ₹372.9b | ₹155.4b | ₹12.0b | 41.4x | 31x | 2.4x |
| Tue, 16 Jan 2024 | ₹368.8b | ₹145.0b | ₹5.3b | 59.5x | 70.2x | 2.5x |
| Thu, 14 Dec 2023 | ₹328.2b | ₹145.0b | ₹5.3b | 54.2x | 62.5x | 2.3x |
| Sat, 11 Nov 2023 | ₹302.0b | ₹133.2b | ₹4.7b | 48.6x | 64.4x | 2.3x |
| Mon, 09 Oct 2023 | ₹347.6b | ₹133.8b | ₹4.8b | 33x | 72.7x | 2.6x |
| Wed, 06 Sep 2023 | ₹348.4b | ₹133.8b | ₹4.8b | 29.6x | 72.9x | 2.6x |
| Fri, 04 Aug 2023 | ₹333.0b | ₹120.4b | ₹4.5b | 42.6x | 73.9x | 2.8x |
| Sun, 02 Jul 2023 | ₹344.9b | ₹120.4b | ₹4.5b | 42x | 76.5x | 2.9x |
Price to Earnings Ratio
76.5x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 165x which is higher than its 3-year average PE of 67.3x.
- The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 15% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 0.25% | |
| Healthcare | 3.29% | |
| Biotech | 2.48% | |
| Biotech | 2.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹420.65 | 2.1% +₹14.2b | 19.7% | PE176.5x | |
| 524669 Hester Biosciences | ₹2.24k | 9.1% +₹1.6b | 20.8% | PE34.3x | |
| PANACEABIO Panacea Biotec | ₹556.05 | 4.5% +₹1.5b | 31.1% | PS5.3x | |
| 514336 CCME Global | ₹126.00 | 16.8% +₹819.0m | n/a | PS16290x | |
| 524663 Bharat Immunologicals & Biologicals | ₹17.75 | 4.1% +₹30.2m | -25.8% | n/a |